Oz Biopharma Biz Argent To Exit London, Mulls US Listing
Argent Biopharma said on Friday it will become the latest company to leave the London Stock Exchange, as the drugmaker pointed to the financial and administrative costs associated with having a listing...To view the full article, register now.
Already a subscriber? Click here to view full article